Trump’s FDA nominee dodges Sanders’ questions about universal health care throughout his testimony
Sen. Bernie Sanders presses Trump FDA pick Overton on healthcare as a human right; she repeatedly sidesteps his questions.
CLAY TRIBUNE / THE ARCHIVE
Tag: FDA
Trump’s FDA Nominee Overton Faces Senators’ Questions on Vaccines, Abortion Pills and Whether She Can Tell the President He’s Wrong
Senators grill Trump's FDA nominee Overton on abortion pills, vaccines, and whether she can tell the president he's wrong.
Trump’s Pick for FDA Chief Faces Senators Today in Highly Anticipated Hearing
Trump's FDA pick Heidi Overton faces Senate hearing amid vaccine controversy and questions about her experience.
Cassidy Says Trump’s Vaccine Message Overlays ‘Don’t Work’ as Measles Cases Surge
Sen. Bill Cassidy urges Trump to 'radically honestly' address vaccines amid a measles outbreak, after the president's unsupported claims.
Drug makers want Congress to let them keep patents for two decades to fight generic competition
Drug makers seek a 10-year patent extension to match costly drug development timelines.
Coffee Makers Add a Substance That Could Be Dangerous — and the FDA Allows It By Law
Coffee may contain crushed scale bugs and beetle debris, legally allowed by the FDA — except cockroaches.
FDA Examines Rising Off-Label Use of Testosterone Prescriptions for Menopause
FDA examines rising off-label testosterone prescriptions for menopausal women, with safety questions still unanswered.
Pharmalittle: Licensing Deals With China, Post-Market Study Delays, and Making Drugs in Space
A weekly digest of pharmaceutical news: licensing deals with China, delayed post-market studies, and drugmaking beyond Earth.
FDA says its hiring freeze has created a staffing crisis so deep it can’t even afford to lift it
A tale of a grand office whose staff is too few to hire more, a circular sorrow wherein hiring itself is the barrier.
FDA Hiring Slowdown Hits Review Backlog as DOGE Funding Cuts Take Effect
The FDA's hiring spree is stuck in bureaucratic limbo, while a new CEO joins Bavarian Nordic and chimera mice raise troubling ethical questions.
FDA’s Rebuilding Effort Stuck in Bureaucratic Delays Created by DOGE Cuts
The FDA's push to hire back 2,000 staff is caught in bureaucratic delays born of its own cuts.
AI Leaders Warn of Growing Risks as Iran Faces Fresh Gulf Diplomatic Hurdles
Key leaders warn AI is advancing too fast for safety. Iran-Gulf diplomacy stalls as the Strait of Hormuz talks are delayed.